Robert Cyran, U.S. tech columnist, joined Breakingviews in London in 2003 and moved four years later to New York, where he continues to cover global technology, pharmaceuticals and special situations. Robert began his career at Forbes magazine, where he assisted in the startup of the international version of the magazine. Before working at Breakingviews he worked as a market researcher and reporter covering the pharmaceutical industry. Robert has a Masters degree in economics from Birmingham University and an undergraduate degree from George Washington University. Follow Rob on Twitter @rob_cyran
- Tel: +1 646 223 6083
- E-mail: email@example.com
Breakneck expansion at the web retailer’s cloud computing unit recalls Amazon’s glory years. Companies are seeing the benefits of letting someone else handle servers, storage and software. This time, the Jeff Bezos playbook contains a welcome wrinkle: growth and maybe profit.
The social network spent 30 pct of Q1 sales developing new products. That’s proportionately about twice as much as Google and 10 times the outlay at Apple. At 42 pct, top line expansion fell short of expectations. To keep it up, all the investment needs to bear fruit.
The Israeli drugmaker needs a deal to shore up falling sales. Smaller rival Mylan offers that and oodles of synergies. A tie-up, though, would face antitrust concerns, require high leverage and have to get around a powerful poison pill. No wonder the market is skeptical.
- GE's higher sum may reflect most of the parts
- Actelion's pay spat reflects tech myopia
- EU's competition sprawl as worrying as Google's
- Qualcomm activist spat a lesson for Silicon Valley
- GE shows way by ending wait for tax Godot
- LinkedIn adds mission creep to its bulging résumé
- Zynga's multi-level StockVille proving hard to win